Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Receives Consensus Rating of "Buy" from Analysts

Retrieved on: 2021-02-06 09:33:45

Tags for this article:

Click the tags to see associated articles and topics

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Receives Consensus Rating of "Buy" from Analysts. View article details on hiswai:

Excerpt

Charles Schwab Investment Management Inc. now owns 377,157 shares of the biopharmaceutical company's stock worth $28,208,000 after buying an ...

Article found on: www.marketbeat.com